{"id":209,"date":"2018-10-26T23:14:59","date_gmt":"2018-10-27T06:14:59","guid":{"rendered":"https:\/\/derm-biomepharmaceuticals.com\/?p=209"},"modified":"2019-01-23T23:54:24","modified_gmt":"2019-01-24T07:54:24","slug":"derm-biome-pharmaceuticals-inc-commences-testing-its-proprietary-compounds-on-skin-microbiome-targets","status":"publish","type":"post","link":"https:\/\/derm-biomepharmaceuticals.com\/ch\/derm-biome-pharmaceuticals-inc-commences-testing-its-proprietary-compounds-on-skin-microbiome-targets\/","title":{"rendered":"Derm-Biome Pharmaceuticals Inc. \u5f00\u59cb\u9488\u5bf9\u76ae\u80a4\u5fae\u751f\u7269\u7ec4\u76ee\u6807\u6d4b\u8bd5\u5176\u4e13\u6709\u5316\u5408\u7269\u3002"},"content":{"rendered":"<p>[vc_row css_animation=&#8221;&#8221; row_type=&#8221;row&#8221; use_row_as_full_screen_section=&#8221;no&#8221; type=&#8221;full_width&#8221; angled_section=&#8221;no&#8221; text_align=&#8221;left&#8221; background_image_as_pattern=&#8221;without_pattern&#8221;][vc_column][vc_column_text]<\/p>\n<h4>2018 \u5e74 10 \u6708 26 \u65e5<\/h4>\n<p>\u4e0d\u5217\u98a0\u54e5\u4f26\u6bd4\u4e9a\u7701\u6e29\u54e5\u534e\u2014\u2014\u603b\u90e8\u4f4d\u4e8e\u6e29\u54e5\u534e\u7684\u5fae\u751f\u7269\u7ec4\u521d\u521b\u516c\u53f8 Derm-Biome Pharmaceuticals Inc. \u5f88\u9ad8\u5174\u5730\u5ba3\u5e03\uff0c\u8be5\u516c\u53f8\u5df2\u4e0e\u836f\u7269\u7814\u7a76\u4e0e\u5f00\u53d1\u4e2d\u5fc3 (CDRD) \u7b7e\u7ea6\uff0c\u5f00\u59cb\u6d4b\u8bd5\u5176\u4e13\u5229\u5316\u5408\u7269\u5bf9\u5404\u79cd\u75c5\u539f\u4f53\u7684\u4f5c\u7528\u3002\u5148\u5bfc\u5316\u5408\u7269 DB-207 \u5728\u6cbb\u7597\u75e4\u75ae\u3001\u7ea2\u6591\u75e4\u75ae\u3001\u8f7b\u5fae\u76ae\u80a4\u7ec6\u83cc\u611f\u67d3\u3001\u7ed3\u819c\u708e\u548c\u80bf\u7624\u6027\u76ae\u80a4\u75c5\u60a3\u8005\u65b9\u9762\u663e\u793a\u51fa\u5de8\u5927\u7684\u6f5c\u529b\uff0c\u5e76\u5177\u6709\u6539\u5584\u5468\u56f4\u76ae\u80a4\u5916\u89c2\u7684\u6709\u76ca\u526f\u4f5c\u7528\u3002\u5c61\u83b7\u6b8a\u8363\u7684\u7814\u7a76\u5458 Poul Sorensen \u535a\u58eb\u548c\u4ed6\u5728 BC \u764c\u75c7\u7814\u7a76\u4e2d\u5fc3\u7684\u5b9e\u9a8c\u5ba4\u5c06\u5f88\u5feb\u5f00\u59cb\u6d4b\u8bd5 DB-207 \u5bf9\u708e\u75c7\u548c\u76ae\u80a4\u764c\u7684\u5f71\u54cd\u3002\u8be5\u516c\u53f8\u6700\u521d\u7684\u91cd\u70b9\u5c06\u662f\u5316\u5986\u54c1\uff08\u6297\u8870\u8001\u4ea7\u54c1\uff09\u4ee5\u53ca\u708e\u75c7\u548c\u80bf\u7624\u6027\u76ae\u80a4\u75c5\u9886\u57df\uff0c\u8fd9\u4e24\u4e2a\u9886\u57df\u90fd\u63d0\u4f9b\u4e86\u5de8\u5927\u7684\u5e02\u573a\u673a\u4f1a\u3002<\/p>\n<h4>\u5173\u4e8e Derm-Biome \u5236\u836f\u516c\u53f8<\/h4>\n<p>Derm-Biome Pharmaceuticals Inc. \u662f\u4e00\u5bb6\u521d\u521b\u751f\u547d\u79d1\u5b66\u516c\u53f8\uff0c\u62e5\u6709\u6db5\u76d6\u56db\u5341\u591a\u79cd\u4f18\u5316\u5929\u7136\u5316\u5408\u7269\u7684\u4e13\u5229\uff0c\u6d89\u8db3\u76ae\u80a4\u5fae\u751f\u7269\u8fd9\u4e00\u4ee4\u4eba\u5174\u594b\u7684\u65b0\u9886\u57df\u3002\u8be5\u516c\u53f8\u611f\u5230\u5174\u594b\u7684\u662f\uff0c\u5176\u5316\u5408\u7269\u80fd\u591f\u5e73\u8861\u6211\u4eec\u72ec\u7279\u7684\u7ec6\u83cc\u7fa4\u843d\u5e76\u589e\u52a0\u5176\u591a\u6837\u6027\uff0c\u7a33\u5b9a\u7684\u73af\u5883\u53ef\u4ee5\u79ef\u6781\u5f71\u54cd\u6211\u4eec\u7684\u76ae\u80a4\u5065\u5eb7\u3001\u6539\u5584\u5916\u89c2\u5e76\u9884\u9632\u5305\u62ec\u76ae\u80a4\u764c\u5728\u5185\u7684\u75be\u75c5\u3002\u6b64\u5916\uff0c\u8fd9\u4e9b\u5316\u5408\u7269\u5bf9\u7ec6\u80de\u751f\u957f\u548c\u5b58\u6d3b\u6709\u76f4\u63a5\u5f71\u54cd\uff0c\u76ee\u524d\u8be5\u516c\u53f8\u6b63\u5728\u5bf9\u6b64\u8fdb\u884c\u7814\u7a76\u3002<\/p>\n<h4>\u8054\u7cfb\u65b9\u5f0f<\/h4>\n<p><strong>Derm-Biome \u5236\u836f\u516c\u53f8<\/strong><br \/>\n\u6295\u8d44\u8005\u67e5\u8be2\uff1a<br \/>\n\u6208\u5fb7\u00b7\u57c3\u4f2f\u6e29<br \/>\ngeberwein@derm-biome.com[\/vc_column_text][vc_separator type=&#8221;normal&#8221; color=&#8221;#cccccc&#8221; thickness=&#8221;1&#8243; up=&#8221;50&#8243; down=&#8221;50&#8243;][\/vc_column][\/vc_row]<\/p>","protected":false},"excerpt":{"rendered":"<p>[vc_row css_animation=&#8221;&#8221; row_type=&#8221;row&#8221; use_row_as_full_screen_section=&#8221;no&#8221; type=&#8221;full_width&#8221; angled_section=&#8221;no&#8221; text_align=&#8221;left&#8221; background_image_as_pattern=&#8221;without_pattern&#8221;][vc_column][vc_column_text] October 26, 2018 VANCOUVER, British Columbia \u2014 Vancouver based microbiome startup Derm-Biome Pharmaceuticals Inc. is excited to announce that it has contracted the Centre for Drug Research and Development (CDRD) to commence testing its patented compounds on various pathogens. Lead compound DB-207 shows significant potential in patients [&hellip;]<\/p>","protected":false},"author":2,"featured_media":219,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[5],"tags":[],"class_list":["post-209","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-recent-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Derm-Biome Pharmaceuticals Inc. commences testing its proprietary compounds on skin microbiome targets. - Derm-Biome Pharmaceuticals Inc.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/derm-biomepharmaceuticals.com\/ch\/derm-biome-pharmaceuticals-inc-commences-testing-its-proprietary-compounds-on-skin-microbiome-targets\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Derm-Biome Pharmaceuticals Inc. commences testing its proprietary compounds on skin microbiome targets. - Derm-Biome Pharmaceuticals Inc.\" \/>\n<meta property=\"og:description\" content=\"[vc_row css_animation=&#8221;&#8221; row_type=&#8221;row&#8221; use_row_as_full_screen_section=&#8221;no&#8221; type=&#8221;full_width&#8221; angled_section=&#8221;no&#8221; text_align=&#8221;left&#8221; background_image_as_pattern=&#8221;without_pattern&#8221;][vc_column][vc_column_text] October 26, 2018 VANCOUVER, British Columbia \u2014 Vancouver based microbiome startup Derm-Biome Pharmaceuticals Inc. is excited to announce that it has contracted the Centre for Drug Research and Development (CDRD) to commence testing its patented compounds on various pathogens. Lead compound DB-207 shows significant potential in patients [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/derm-biomepharmaceuticals.com\/ch\/derm-biome-pharmaceuticals-inc-commences-testing-its-proprietary-compounds-on-skin-microbiome-targets\/\" \/>\n<meta property=\"og:site_name\" content=\"Derm-Biome Pharmaceuticals Inc.\" \/>\n<meta property=\"article:published_time\" content=\"2018-10-27T06:14:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-01-24T07:54:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/derm-biomepharmaceuticals.com\/wp-content\/uploads\/2018\/10\/2018Oct-Announcement-cover.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"539\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Derm-Biome Admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Derm-Biome Admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-commences-testing-its-proprietary-compounds-on-skin-microbiome-targets\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-commences-testing-its-proprietary-compounds-on-skin-microbiome-targets\/\"},\"author\":{\"name\":\"Derm-Biome Admin\",\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/#\/schema\/person\/7fd946a95040e8683129145f79976d8d\"},\"headline\":\"Derm-Biome Pharmaceuticals Inc. commences testing its proprietary compounds on skin microbiome targets.\",\"datePublished\":\"2018-10-27T06:14:59+00:00\",\"dateModified\":\"2019-01-24T07:54:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-commences-testing-its-proprietary-compounds-on-skin-microbiome-targets\/\"},\"wordCount\":288,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-commences-testing-its-proprietary-compounds-on-skin-microbiome-targets\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/derm-biomepharmaceuticals.com\/wp-content\/uploads\/2018\/10\/2018Oct-Announcement-cover.jpg\",\"articleSection\":[\"Recent News\"],\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-commences-testing-its-proprietary-compounds-on-skin-microbiome-targets\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-commences-testing-its-proprietary-compounds-on-skin-microbiome-targets\/\",\"url\":\"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-commences-testing-its-proprietary-compounds-on-skin-microbiome-targets\/\",\"name\":\"Derm-Biome Pharmaceuticals Inc. commences testing its proprietary compounds on skin microbiome targets. - Derm-Biome Pharmaceuticals Inc.\",\"isPartOf\":{\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-commences-testing-its-proprietary-compounds-on-skin-microbiome-targets\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-commences-testing-its-proprietary-compounds-on-skin-microbiome-targets\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/derm-biomepharmaceuticals.com\/wp-content\/uploads\/2018\/10\/2018Oct-Announcement-cover.jpg\",\"datePublished\":\"2018-10-27T06:14:59+00:00\",\"dateModified\":\"2019-01-24T07:54:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-commences-testing-its-proprietary-compounds-on-skin-microbiome-targets\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-commences-testing-its-proprietary-compounds-on-skin-microbiome-targets\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-commences-testing-its-proprietary-compounds-on-skin-microbiome-targets\/#primaryimage\",\"url\":\"https:\/\/derm-biomepharmaceuticals.com\/wp-content\/uploads\/2018\/10\/2018Oct-Announcement-cover.jpg\",\"contentUrl\":\"https:\/\/derm-biomepharmaceuticals.com\/wp-content\/uploads\/2018\/10\/2018Oct-Announcement-cover.jpg\",\"width\":1000,\"height\":539},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-commences-testing-its-proprietary-compounds-on-skin-microbiome-targets\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/derm-biomepharmaceuticals.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Derm-Biome Pharmaceuticals Inc. commences testing its proprietary compounds on skin microbiome targets.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/#website\",\"url\":\"https:\/\/derm-biomepharmaceuticals.com\/\",\"name\":\"Derm-Biome Pharmaceuticals Inc.\",\"description\":\"Startup Biopharmaceutical Company\",\"publisher\":{\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/derm-biomepharmaceuticals.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/#organization\",\"name\":\"Derm-Biome Pharmaceuticals\",\"url\":\"https:\/\/derm-biomepharmaceuticals.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/derm-biomepharmaceuticals.com\/wp-content\/uploads\/2019\/01\/Derm-Biome-Pharmaceuticals-white-1.png\",\"contentUrl\":\"https:\/\/derm-biomepharmaceuticals.com\/wp-content\/uploads\/2019\/01\/Derm-Biome-Pharmaceuticals-white-1.png\",\"width\":450,\"height\":200,\"caption\":\"Derm-Biome Pharmaceuticals\"},\"image\":{\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/#\/schema\/person\/7fd946a95040e8683129145f79976d8d\",\"name\":\"Derm-Biome Admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/derm-biomepharmaceuticals.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/010b14acf7a9fd5e8fbbc766302fccb7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/010b14acf7a9fd5e8fbbc766302fccb7?s=96&d=mm&r=g\",\"caption\":\"Derm-Biome Admin\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Derm-Biome Pharmaceuticals Inc. commences testing its proprietary compounds on skin microbiome targets. - Derm-Biome Pharmaceuticals Inc.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/derm-biomepharmaceuticals.com\/ch\/derm-biome-pharmaceuticals-inc-commences-testing-its-proprietary-compounds-on-skin-microbiome-targets\/","og_locale":"zh_CN","og_type":"article","og_title":"Derm-Biome Pharmaceuticals Inc. commences testing its proprietary compounds on skin microbiome targets. - Derm-Biome Pharmaceuticals Inc.","og_description":"[vc_row css_animation=&#8221;&#8221; row_type=&#8221;row&#8221; use_row_as_full_screen_section=&#8221;no&#8221; type=&#8221;full_width&#8221; angled_section=&#8221;no&#8221; text_align=&#8221;left&#8221; background_image_as_pattern=&#8221;without_pattern&#8221;][vc_column][vc_column_text] October 26, 2018 VANCOUVER, British Columbia \u2014 Vancouver based microbiome startup Derm-Biome Pharmaceuticals Inc. is excited to announce that it has contracted the Centre for Drug Research and Development (CDRD) to commence testing its patented compounds on various pathogens. Lead compound DB-207 shows significant potential in patients [&hellip;]","og_url":"https:\/\/derm-biomepharmaceuticals.com\/ch\/derm-biome-pharmaceuticals-inc-commences-testing-its-proprietary-compounds-on-skin-microbiome-targets\/","og_site_name":"Derm-Biome Pharmaceuticals Inc.","article_published_time":"2018-10-27T06:14:59+00:00","article_modified_time":"2019-01-24T07:54:24+00:00","og_image":[{"width":1000,"height":539,"url":"https:\/\/derm-biomepharmaceuticals.com\/wp-content\/uploads\/2018\/10\/2018Oct-Announcement-cover.jpg","type":"image\/jpeg"}],"author":"Derm-Biome Admin","twitter_card":"summary_large_image","twitter_misc":{"\u4f5c\u8005":"Derm-Biome Admin","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"1 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-commences-testing-its-proprietary-compounds-on-skin-microbiome-targets\/#article","isPartOf":{"@id":"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-commences-testing-its-proprietary-compounds-on-skin-microbiome-targets\/"},"author":{"name":"Derm-Biome Admin","@id":"https:\/\/derm-biomepharmaceuticals.com\/#\/schema\/person\/7fd946a95040e8683129145f79976d8d"},"headline":"Derm-Biome Pharmaceuticals Inc. commences testing its proprietary compounds on skin microbiome targets.","datePublished":"2018-10-27T06:14:59+00:00","dateModified":"2019-01-24T07:54:24+00:00","mainEntityOfPage":{"@id":"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-commences-testing-its-proprietary-compounds-on-skin-microbiome-targets\/"},"wordCount":288,"commentCount":0,"publisher":{"@id":"https:\/\/derm-biomepharmaceuticals.com\/#organization"},"image":{"@id":"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-commences-testing-its-proprietary-compounds-on-skin-microbiome-targets\/#primaryimage"},"thumbnailUrl":"https:\/\/derm-biomepharmaceuticals.com\/wp-content\/uploads\/2018\/10\/2018Oct-Announcement-cover.jpg","articleSection":["Recent News"],"inLanguage":"zh-Hans","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-commences-testing-its-proprietary-compounds-on-skin-microbiome-targets\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-commences-testing-its-proprietary-compounds-on-skin-microbiome-targets\/","url":"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-commences-testing-its-proprietary-compounds-on-skin-microbiome-targets\/","name":"Derm-Biome Pharmaceuticals Inc. commences testing its proprietary compounds on skin microbiome targets. - Derm-Biome Pharmaceuticals Inc.","isPartOf":{"@id":"https:\/\/derm-biomepharmaceuticals.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-commences-testing-its-proprietary-compounds-on-skin-microbiome-targets\/#primaryimage"},"image":{"@id":"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-commences-testing-its-proprietary-compounds-on-skin-microbiome-targets\/#primaryimage"},"thumbnailUrl":"https:\/\/derm-biomepharmaceuticals.com\/wp-content\/uploads\/2018\/10\/2018Oct-Announcement-cover.jpg","datePublished":"2018-10-27T06:14:59+00:00","dateModified":"2019-01-24T07:54:24+00:00","breadcrumb":{"@id":"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-commences-testing-its-proprietary-compounds-on-skin-microbiome-targets\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-commences-testing-its-proprietary-compounds-on-skin-microbiome-targets\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-commences-testing-its-proprietary-compounds-on-skin-microbiome-targets\/#primaryimage","url":"https:\/\/derm-biomepharmaceuticals.com\/wp-content\/uploads\/2018\/10\/2018Oct-Announcement-cover.jpg","contentUrl":"https:\/\/derm-biomepharmaceuticals.com\/wp-content\/uploads\/2018\/10\/2018Oct-Announcement-cover.jpg","width":1000,"height":539},{"@type":"BreadcrumbList","@id":"https:\/\/derm-biomepharmaceuticals.com\/derm-biome-pharmaceuticals-inc-commences-testing-its-proprietary-compounds-on-skin-microbiome-targets\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/derm-biomepharmaceuticals.com\/"},{"@type":"ListItem","position":2,"name":"Derm-Biome Pharmaceuticals Inc. commences testing its proprietary compounds on skin microbiome targets."}]},{"@type":"WebSite","@id":"https:\/\/derm-biomepharmaceuticals.com\/#website","url":"https:\/\/derm-biomepharmaceuticals.com\/","name":"Derm-Biome Pharmaceuticals Inc.","description":"Startup Biopharmaceutical Company","publisher":{"@id":"https:\/\/derm-biomepharmaceuticals.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/derm-biomepharmaceuticals.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/derm-biomepharmaceuticals.com\/#organization","name":"Derm-Biome Pharmaceuticals","url":"https:\/\/derm-biomepharmaceuticals.com\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/derm-biomepharmaceuticals.com\/#\/schema\/logo\/image\/","url":"https:\/\/derm-biomepharmaceuticals.com\/wp-content\/uploads\/2019\/01\/Derm-Biome-Pharmaceuticals-white-1.png","contentUrl":"https:\/\/derm-biomepharmaceuticals.com\/wp-content\/uploads\/2019\/01\/Derm-Biome-Pharmaceuticals-white-1.png","width":450,"height":200,"caption":"Derm-Biome Pharmaceuticals"},"image":{"@id":"https:\/\/derm-biomepharmaceuticals.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/derm-biomepharmaceuticals.com\/#\/schema\/person\/7fd946a95040e8683129145f79976d8d","name":"Derm-Biome Admin","image":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/derm-biomepharmaceuticals.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/010b14acf7a9fd5e8fbbc766302fccb7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/010b14acf7a9fd5e8fbbc766302fccb7?s=96&d=mm&r=g","caption":"Derm-Biome Admin"}}]}},"_links":{"self":[{"href":"https:\/\/derm-biomepharmaceuticals.com\/ch\/wp-json\/wp\/v2\/posts\/209","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/derm-biomepharmaceuticals.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/derm-biomepharmaceuticals.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/derm-biomepharmaceuticals.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/derm-biomepharmaceuticals.com\/ch\/wp-json\/wp\/v2\/comments?post=209"}],"version-history":[{"count":8,"href":"https:\/\/derm-biomepharmaceuticals.com\/ch\/wp-json\/wp\/v2\/posts\/209\/revisions"}],"predecessor-version":[{"id":226,"href":"https:\/\/derm-biomepharmaceuticals.com\/ch\/wp-json\/wp\/v2\/posts\/209\/revisions\/226"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/derm-biomepharmaceuticals.com\/ch\/wp-json\/wp\/v2\/media\/219"}],"wp:attachment":[{"href":"https:\/\/derm-biomepharmaceuticals.com\/ch\/wp-json\/wp\/v2\/media?parent=209"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/derm-biomepharmaceuticals.com\/ch\/wp-json\/wp\/v2\/categories?post=209"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/derm-biomepharmaceuticals.com\/ch\/wp-json\/wp\/v2\/tags?post=209"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}